Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma
The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity
- Journal Title
- Medical Oncology
- Volume 1 / 1984 - Volume 36 / 2019
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
|Previous Title||Print ISSN||Online ISSN|
|Medical oncology and tumor pharmacotherapy||0736-0118||1559-131X|
To view the rest of this content please follow the download PDF link above.